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At present, the release of pharmacologically active mediators by means of an 
in vitro immunologic reaction requires the activity of intact, living ceils.  For 
this reason, studies of the detailed biochemical mechanism of such reactions rely 
heavily on the systematic and judicious use of various classes of inhibitors (1-3). 
Organophosphorus inhibitors such as diisopropylphosphofluoridate (DFP) and 
the phosphonate esters have proved particularly suitable for such studies by 
virtue of their ability to irreversibly and specifically inactivate the so called 
serine esterases (see reference 4 for references). We have recently shown that a 
large number of phosphonate esters of the general structure 
0 
inhibit the antigen-induced release of histamine from sensitized slices of guinea 
pig lung (4). These same phosphonate esters also inhibit the hemolytic activity 
of the first component (Cqa) of guinea pig complement (4, 5).  The effective- 
ness of the inhibitor varies with changes in structure of the R group in a manner 
which is distinctly different for each reaction. On the basis of these differences, 
it was tentatively concluded that the antigen-antibody-activated esterase in- 
volved in histamine release from guinea pig lung was not C'la. 
The tentative nature of this conclusion stemmed mainly from the fact that 
histamine release in tissue slices was compared with lysis of a suspension of sen- 
sitized red cells by complement. Thus, it was possible that some of the differ- 
ences noted refected differences in the ability of the inhibitors to reach target 
cells in the lung tissue. 
* This investigation  was supported in part by a grant from the Allergy Foundation of 
America and United States Pubfic Health Service Grant AI 04536. 
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Attention was therefore directed to the use of suspensions of rat peritoneal 
mast cells rather than tissue slices to study the effect of the phosphonate inhib- 
itors on histamine release. Two quite different methods of inducing  antigen- 
antibody-mediated histamine release from such cells have been described (6), 
only one of which however, is the subject of this paper. This method involves 
antigen-induced  histamine release from well washed rat peritoneal mast cells 
passively sensitized in vitro (7) with the so called "mast cell lyric antibody" (8) 
or "anaphylactic antibody" (9) formed in the rat. This mode of histamine re- 
lease is analogous to that obtained from perfused, sensitized guinea pig lung 
slices on the addition of antigen. Both the rat and guinea pig reactions involve 
the sensitization of the target cell by homologous antibody with fast electro- 
phoretic mobility. In neither case does histamine release by antigen require se- 
rum, nor does the responsible antibody appear to mediate complement-depend- 
ent, passive immune hemolysis (9-11). In what follows, we shall term this, the 
"homocytotropic antibody-mediated release of histamine." The term "anaphy- 
lactic" previously used in this connection, has been abandoned since it refers to 
responses of the whole animal which can involve several different mechanisms. 
In the present work, this form of histamine release has been studied using the 
phosphonate ester inhibitors. In addition, in order to assess the possible role of 
complement in the reaction, the activity of the phosphonate esters against the 
activated first component (C'la) of rat complement was also determined. 
The results obtained have permitted the following comparisons to be made: 
(a) the esterase involved in the homocytotropic antibody-mediated release of 
histamine from rat peritoneal mast cells has been compared with the esterase 
involved in the homocytotropic antibody-mediated release of histamine from 
mast cells of guinea pig lung slices; (b) the esterase involved in the homocyto- 
tropic antibody-mediated release of histamine from rat peritoneal mast cells has 
been  compared with  rat  C'la,  avoiding  the  uncertainties  introduced  in  our 
earlier studies by the use of tissue slices. 
Materials and Methods 
Phosphonate Inhibitors.--The p-nitrophenylethyl, alkyl, phenylalkyl, aminoalkyl, and the 
chloroalkyl-phosphonates,  1 were with few exceptions the same as used in the previous study 
(4). The p-nitrophenyl-ethyl chloropeutyl phosphonate, sample 1 was the same as used previ- 
ously; sample 2 was newly synthesized. The concentrations of phosphonate esters were meas- 
ured in terms of the actual bound p-nitrophenol as determined on the day the experiment was 
performed. 
Buffers.--The  two buffers used in the study of the inhibition of C'la, triethanolamine- 
buffered saline (TBS), and "low ionic strength (0.055/z) buffer, pH 8.0" were the same as 
described previously (4). "Dextrose buffer" consisted of equal parts of 5% dextrose in water 
and TBS (12). 
1  In what follows, the p-nitrophenylethyl phosphonates will be named only according to 
the nature of the R group, the presence of the p-nitrophenoxy and ethoxy groups being ira- 
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Tyrode's buffer with 0.1%  gelatin added was used in all steps of the histamine release 
studies up to and including sensitization. The solution of phosphonates was prepared by add- 
ing 0.1 ml of stock inhibitor in acetone to 59.9 ml of Tyrode's gelatin solution; control Tyrode's 
gelatin buffer without inhibitor contained the same concentration of acetone (0.17%). This 
concentration of acetone was found not to interfere with antigen-antibody-induced histamine 
release. 
Rat C'la.--Partially purified C'la was prepared from fresh or fresh frozen rat serum by 
bringing the salt concentration to 0.04 5, pH 7.5 as described in reference 12. The precipitate 
was dissolved in 2 times concentrated TBS, dispensed in aliquots, and stored at --20°C until 
required. The concentration of effective C'la molecules was estimated as described in reference 
13. 
Red  Cell Intvrmediates.--The  preparation of C'2, EA, EAC'la4,  2a was as described in 
reference 14.  The number of EAC'la4 sites was  determined by the transfer technique of 
Borsos and Rapp (13). EACrlarat4 gp was prepared as follows: The EACh4  gp (1  X  109/ml) 
in TBS was chilled to 0°C, and rat C'la was added in sufficient amount togivea3-fold molec- 
ular excess of rat C'la over EAC'4 sites. The mixture was incubated for 10 rain at  0°C  with 
occasional shaking and then centrifuged in the cold. The cells were washed 2 times with ice 
cold TBS.  They were then washed once in dextrose buffer, and stored at 0°C in the same 
dextrose buffer containing 100 units of penicillin and 50 mcg of streptomycin per ml. In the 
preparation and subsequent use of EAC~la rat, 4 gp no attempt was made to vary the  Ca  ++ 
and Mg  ++ concentrations from that used with guinea pig complement despite the report that 
these are not optimal for rat complement (15). 
Inhibition of C'la.--The procedure for determining the activity of the various phosphonates 
against  rat  C~la  was  somewhat  simplified  from  that  described  previously  (4).  5  ml  of 
EAC'la rat, 4 gp (1.50 X  10S/ml,  20 to 100 effective C~la sites per cell) in low ionic strength 
buffer, pH 8.0, was added to 5 mi of a  1 : 100 dilution of a  stock solution of phosphonate in 
acetone, all at 25°C. By means of accurately calibrated micropipettes, 0.01 to 0.05 ml aliquots 
(the exact volume depending on the number of effective EAC'la, 4 sites initially present) were 
removed at 3 and 10 rain after mixing, and at 10-min intervals thereafter for 60 rain. The 
samples were immediately added to 1 ml of ice cold EAC'4 (7.5 X  l0  T cells/ml) in TBS and 
stored at I°C until sampling was complete. At the end of this time, the contents of the tubes 
were mixed and placed in a 30°C water bath for 15 min for the transfer reaction to occur. 
A control tube containing 5 ml of EAC'la, 4 in low ionic strength, pH 8.0 buffer with 0.05 
ml of acetone added was sampled at zero time, 30 rain, and 1 hr. The samples were treated 
exactly as described above. 
A straight line relationship between the time of contact of the phosphonate with C~la and 
the logarithm of the number of C'la sites remaining was found for rat C'la; this is the same 
relationship as described previously for guinea pig C'la (4). The I60, the molar concentration 
of phosphonate giving 50~o inactivation when inhibitor and cells were allowed to stand 15 
rain at 25°C, and the pIso, the negative logarithm of the Is0, were calculated as described in 
(4). 
Ant~sera for Sensltlzation of Rat Peritoneal  Cd/s.--Rat antisera containing antibody cap- 
able of sensitizing the rat for passive cutaneous anaphylaxis were obtained by injecting rats 
in each foot-pad with 0.25 ml of a  mixture containing 1.0 mg dinitrophenyl-bovine gamma 
globulin  (DNP-BGG)  or  five  times  recrystallized  egg  albumin  (Pentex,  Inc.,  Kankakee, 
Illinois) and 109 Bordetella pertussis organisms per ml. 2 The antisera were collected 7 to 15 
days later and had PCA titers in the rat ranging from 1:9 to 1:81. Rat antisera against the 
9. The  Bordetella  pertussis  organisms  were  generously  supplied  by  Merck,  Sharp,  and 
Dohme, West Point, Pennsylvania. 382  IMMUNOLOGIC INJURY.  I 
worm, Nippostrongylus  brasiliensls (16)  were generously supplied by Dr.  Kurt  Bloch. The 
details of the immunization procedure and preparation of antigen will be published elsewhere 
(17). 
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FIO.  1.  The variation in effectiveness of the inhibitory activity of the p-nitrophenylethyl 
phenylaikyl phosphonate  (A), and  the p-nitrophenylethyl w-chloroalkyl phosphonates,  (B) 
against rat C'la and guinea pig C'la. 
Preparation  of Peritoneal Cell Suspensions.--Peritoneal  cell suspensions  were  obtained 
from  Sprague-Dawley rats as previously described  (18,  19). The cells from each rat  were 
sedimented in plastic centrifuge tubes at 400 g for 2 rain at 4°C, and  resuspended in 2 ml 
Tyrode's gelatin buffer.  The cell suspensions  from 8 to 12 rats were then pooled, centrifuged, 
resuspended in 16 to 24 ml Tyrode's gelatin buffer (2 ml per rat), and washed again. The final 
suspension contained approximately 5% mast cells as determined by phase microscopy; evi- ELMER  L.  BECKER  AND  K.  FRANK  AUSTEN  383 
dence has been presented that the mast cells are the source  of histamine liberated by the 
various experimental procedures (18, 19). 
Homocytotropic Antibody-Mediated H~stamine Release.--In a typical experiment, 24 ml of 
rat peritoneal cell suspension were sedimented and resuspended in a small volume of Tyrode's 
gelatin, usually 1.2 hal. Sensitization was achieved by incubating the cells at 37°C for 2~'~ hr 
with an equal volume of undiluted rat antiserum to DNP or egg albumin, or with a 1:3 dilu- 
tion of antiserum to N. brasiliensis. Restriction of volume increased the rate of sensitization. 
It was necessary to agitate the mixture every S to 10 rain to maintain a uniform suspension. 
At the end of the sensitization  period the cells were diluted with 24 ml Tyrode's gelatin buffer, 
sedimented, and resuspended  in 24 ml Tyrode's gelatin. The cells were divided into 1 ml 
aliquots with a  volumetric pipette, sedimented, and resuspended  in 2 ml Tyrode's gelatin 
buffer with or without phosphonate inhibitor. Following preincubation at 37°C, 0.1  ml of 
specific antigen was added and the reaction mixture was incubated for 7 rain. The cells were 
TABLE I 
Inhibition of Rabbit and Guinea Pig C'la by Pentyl Phosphonate, 5-Aminopentyl Phosphonate, 
and 5-Chloropentyl Phosphonate 
Phosphonate 
Pentyl phosphonate 
5-aminopentyl phosphonate 
5-chloropentyl phosphonate 
Inhibition (I~0) 
Rat C'la 
M 
1.0  X  10  -8 
3.1  X  10  -e 
1.9  X  10  -a 
Guinea pig C'la 
M 
1.4 X  10  -8 
1.5 X  10  -5 
3.5 ×  10  -3 
then sedimented by centrifugation at 400 g for 4 rain, and the supernatant fluid and cells 
analyzed for histamine (2).  Each variable was studied using 3 cell samples,  two received 
specific antigen, and the third which did not receive antigen served as a control for the spon- 
taneous histamine release.  Unsensitized  cells from  the same pool were aiso reacted with 
antigen to exdude any nonspecific histamine release by antigen alone.  Duplicate samples 
gave values for histamine release which were within 3% of each other. 
RESULTS 
E~ect of Phosphonates on Inhibition of C'la.--The inhibition of rat and guinea 
pig C'la by the phenylalkyl phosphonates, and by the chloroalkyl phosphonates 
is seen in Fig. 1, A  and B, respectively. The inhibition of rat C'la was deter- 
mined for this study, that of guinea pig C'la was taken from the previous in- 
vestigation (4). The very great similarity in the patterns of the inhibition of the 
enzyme from the two different sources is evident in both series of phosphonates. 
The only real difference is that the benzyl phosphonate shows peak activity with 
guinea pig C'la, whereas, with rat C'la, the phenyl phosphonate gives maxi- 
mum inhibition. 
Table I  shows the inhibition of rat, and guinea pig C'la by 5-aminopentyl 
phosphonate, 5-chloropentyl phosphonate, and pentyl phosphonate. The 5-ami- 
nopentyl phosphonate was a much more active inhibitor of both rat and guinea 384  IMMUNOLOGIC  INJURY.  I 
pig C'la than was the pentyl phosphonate, and the pentyl phosphonate was a 
better inhibitor than the 5-chloropentyl phosphonate. 
Effect of Phosphonates on Homocytotropic Antibody-Mediated  Histamine Re- 
lease.- 
Effect of impurities:  Fig.  2 illustrates the different types of curves obtained 
when  varying concentrations  of the  two available samples of 5-chloropentyl 
phosphonate were compared for their capacity to prevent histamine release. As 
in  all experiments,  the  antigen-antibody-induced  histamine  release  was cor- 
rected for spontaneous release. With sample 1 there was a linear relation be- 
tween the per cent histamine release remaining and the molar concentration of 
phosphonate inhibitor;  the data extrapolate back to  100 per cent antigen-in- 
duced histamine release at zero concentration of inhibitor. With sample 2 there 
was also a straight line relationship between the per cent histamine release re- 
maining and the dose of inhibitor, but this line extrapolates to much greater 
than 100 % histamine release at zero concentration of inhibitor. At the lowest 
concentration tested, sample 2 gave 160 % enhancement. 
The different dose response curves elicited by the two samples in the presence 
of an antigen-antibody reaction was associated with a distinct difference in the 
effect of these two preparations on the release of the histamine in the absence 
of an immune reaction. As shown in Table II, the spontaneous, or nonantigen- 
antibody-induced release of histamine rose greatly with increasing concentra- 
tions of sample 2; there was no such concentration dependent increase in spon- 
taneous histamine release with sample 1. 
This anomalous behavior of sample 2 can be ascribed to an impurity present 
in the preparation and not to the phosphonate itself since it was not observed 
with the other sample of the same compound. The impurity must be present in 
quite small amounts; gas liquid chromatography of sample 2 indicated that the 
compound was essentially pure. 
Similar aberrant effects were found with one of the three samples of pentyl 
phosphonate, and in the single available samples of the 6-aminohexyl phospho- 
nate and the 6-chlorohexyl phosphonate. Since such anomalous behavior could 
not be predicted from the physical properties of the phosphonates, it was neces- 
sary to set up rigid standards which a compound had to meet before it could be 
used for comparative purposes. Every compound was tested for and shown to 
meet the two following requirements before any conclusions were drawn as to 
its relative activity. 
1.  The compound had to give a linear relationship between concentration of 
phosphonate and per cent inhibition of immunologic histamine release which 
extrapolated to zero inhibition at zero concentration of inhibitor. 
2.  The rat peritoneal mast cells did not give an increase in histamine release 
when exposed to increasing concentrations of the compound in the absence of 
an antigen-antibody reaction. 
Dose-Response Curves.--Ten compounds in all were shown to fulfill the above ELMER  L.  BECKER  AND  K.  FRANK  AUSTEN  385 
two conditions. The dose response curves given by the phenyl, benzyl, phenyl- 
ethyl, and phenylpropyl phosphonates are shown in Fig. 3, A, and the dose- 
response curves for the 2-chloroethyl, 2-chloropropyl,  4-chlorobutyl, 5-chloro- 
pentyl, pentyl, and 5-aminopentyl phosphonates are given in Fig. 3, B. 
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FIG. 2.  The differences in the effect on antigen-induced histamine release exerted by vary- 
ing concentrations of two samples of p-nitrophenylethyl 5-chloropentyl phosphonate. Antigen- 
induced histamine release in buffer without inhibitor was assigned a  value of 100  per cent. 
Mast cells sensitized with rat antiovalbumin 2. 386  IMMUNOLOGIC  INJURY.  I 
In the same experiments in which the dose-response curves were obtained, the 
behavior of the controls with added phosphonate but without added  antigen 
allowed us to ascertain that these same 10 compounds also fulfilled the second 
condition. 
Demonstration that  the Phosphonates Do Not Act Irreversibly  on  the  Cells.- 
Mast cells were sensitized with rat antibody to the worm, N. brasiliensis. In one 
series of tubes the cells were resuspended in either 2 ml of 2 X  10  -4 ~  phenyl- 
propyl phosphonate, 8.0  X  10  -4 M benzyl phosphonate, 6.0  X  ]0-4 ~  4-chloro- 
butyl phosphonate  in  Tyrode's gelatin  or in  a  control  of  0.17 %  acetone in 
Tyrode's gelatin. After 5  man at 37°C,  the cells were sedimented by centrifu- 
TABLE II 
Effect of Two Different Samples oJ 5-Chloropentyl Phosphonate on the Spontaneous Release of 
Histamine from Rat Perltone4l Mas~ Cells 
Sample 1  Sample 2 
Concentration  Histamine release  Concentration  Histamine release 
X  104  M 
0 
1.3 
2.5 
3.5 
mlzg/ml 
2O 
50 
50 
60 
X  10 4 I~ 
0 
2.0 
4.0 
6.0 
raug/ral 
20 
80 
160 
250 
gation, washed once, resuspended in 2 ml Tyrode's gelatin with 0.17 % acetone 
and challenged with the N. brasiliensis antigen. In a second series of tubes, sensi- 
tized mast cells were exposed to the same concentrations of the same inhibitors. 
Antigen was added while the cells were still in the presence of the inhibitors.  The 
amount of histamine released under both these circumstances was determined 
as usual. 
The results are seen in Table III.  Incubation of sensitized mast cells with 
inhibitor before, but not  during the addition of antigen, had no effect on the 
resultant antigen-induced release of histamine. However, these same inhibitors 
gave 55 to 85 % inhibition when present during the addition of antigen to the 
sensitized mast cells. In  another experiment, the same three inhibitors at the 
same concentration gave similar results with mast cells sensitized to egg albu- 
min. 
In still another experiment, cells sensitized to DNP bovine "y-globulin were 
incubated with 3.0 X  10  -4 M 5-aminopentyl phosphonate; after removal of the 
inhibitor by washing, the cells gave the expected antigen-induced release of his- 
tamine. However, 79 % inhibition was obtained when DNP-bovine serum albu- 
min was added in the presence of the aminopentyl phosphonate. ~.~-~ 
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TABLE III 
Effect oJ Phosphonates  on  the Sensiazed  Mast  Cells in the Presence  and  Absence  of Antigen 
Concentration 
X  10 4  M 
0 
2.0 
8.0 
6.0 
Phosphonate 
Phenylpropyl 
Benzyl 
4-chlorobutyl 
Histamine release as per cent of control* 
Phosphonates present 
before  but not during 
addition  of antigen 
100 
81 
106 
100 
Phosphonate present 
i  during addition 
of antigen 
100 
45 
15 
29 
* Control refers to antigen-induced release of histamine from replicate cells never exposed 
to phosphonate. 
o 
D. 
4.0 
3.5 
3.0 
2.5 
A. PHENYLALKYL  PHOSPHONATES  B. CHLOROALKYL PHOSPHONATES 
Fro. 4.  The effect of the structure of the p-nitrophenylethyl phenylalkyl phosphonates (A) 
and the p-nitrophenylethyl chloroalkyl phosphonates  (B)  on their ability to inhibit homo- 
cytotropic  antibody-mediated  histamine  release.  The  experiment  with  the  phenylalkyl 
phosphonates  was performed with mast cells sensitized with rat antiovaibumin 6,  and the 
experiment with the chloroalkyl phosphonates was done with ceils sensitized with rat anti-N. 
brasiliensis. 
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These studies indicate that the phosphonate esters do not react irreversibly 
on the cells but are acting only on an antigen-antibody-activated esterase. 
Effect of Structure on the Activity of the Phosphonate Inhibitors.--The 1"6o, the 
concentration of inhibitor giving 50 % inhibition, was obtained for each phos- 
phonate by plotting the per cent inhibition against inhibitor concentration. 
From this the pI*~o, the negative logarithm of the 1"50 was calculated. As pre- 
viously (4), the * signifies that the time interval over which the inhibitor is act- 
ing is unknown. Comparison of the activity of a given series of inhibitors, or of 
one inhibitor with another, was only made within the same experiment. 
Fig. 4, A  shows that in the aromatic series,  the inhibitory power increases 
regularly in going from the phenylphosphonate to the phenylpropyl phospho- 
nate. 
In the chloroalkyl series  (Fig. 4, B) there is a distinct increase in inhibitory 
effectiveness of the 3-chloropropyl phosphonate compared to the 2-chloroethyl 
phosphonate.  There is little, if any,  demonstrable difference between the 3- 
chloropropyl and 4-chlorobutyl phosphonates, whereas the 5-chloropentyl phos- 
phonate is distinctly more effective than either. 
As seen in Table IV, among the three pentyl phosphonates, the 5-aminopentyl 
phosphonate is the best inhibitor, the 5-chloropentyl phosphonate, intermedi- 
ate, and the pentyl phosphonate is the least active. 
TABLE IV 
Ability of Pentyl Phospkonate, 5-Aminopentyl Pttosphonate, and 5-Chloropentyl Phosphonate to 
Inhibit the Homocytotropic Antibody--Mediated Release of Histamine 
Phosphonate  150" 
M 
Pentyl phosphonate  13  X  10  -4 
5-aminopentyl phosphonate  2.7  X  10  -4 
5-chloropentyl  phosphonate  3.5  ×  10  -q 
DISCUSSION 
The results just described demonstrate a clear-cut inhibition of histamine re- 
lease by the various phosphonate esters. This is in sharp contrast to the equiv- 
ocal inhibition of the same reaction by diisopropylphosphoflouridate (DFP) 
found by Perrara and Mongar (20). They reported that 10- 4 ~ DFP, an organo- 
phosphorus inhibitor with the same mode of action as the phosphonates, gave 
10 to 15 % inhibition of histamine release, whereas, 10  -8 M DFP gave a 200 % 
enhancement. 
Perrara and Mongar ascribed the enhancement at the higher and inhibition 
at the lower concentration of DFP to the action of the inhibitor on more than 390  IMMUNOLOGIC  INJURY.  I 
one step in the sequence of reactions leading to histamine release. Our results 
show that the enhancement of antigen-antibody-induced histamine release by 
certain concentrations of some of the phosphonates is due to an impurity in the 
phosphonate preparation (Fig. 2 and Table II). In the sliced guinea pig lung 
system, there was no discernible effect of the impurity present in these same 
phosphonates (4), and DFP showed none of the puzzling behavior seen in the 
rat mast cell system (2, 4, 20). It is quite possible that the anomalous behavior 
of DFP found by Perrara and Mongar is not attributable to a  dual action of 
DFP, as they suggest, but rather to an impurity in their preparation. In this 
regard, it is of interest that certain samples of DFP have been shown to possess 
an impurity which is capable of reacting with sulfhydryl-requiring proteolytic 
enzymes such as ficin (21). 
The dose-dependent inactivation of histamine release is only obtained when 
the phosphonates are present during the addition of antigen; there is a complete 
lack of effect when these same compounds are added to the mast cells and re- 
moved before the addition of antigen. In conjunction with the well known ir- 
reversible nature of the inhibition by phosphonates this implies that the phos- 
phonates  suppress  homocytotropic antibody-mediated histamine  release  by 
inhibiting an antigen-antibody-activated esterase. The esterase exists in or on 
the cell in a phosphonate-resistant precursor form until activated by antigen- 
antibody interaction. This is the same conclusion reached regarding the esterase 
involved in  antigen-induced release of histamine from sensitized guinea pig 
lung (4). 
The effectiveness of the phenylalkyl phosphonates in inhibiting histamine re- 
lease from rat peritoneal mast cells increases with increasing chain length; there 
is also a tendency for the inhibitory activity of the chloroalkyl phosphonates to 
be enhanced by lengthening the alkyl chain. Chymotrypsin reacts with these 
phosphonates in essentially the same way (22). The greater effectiveness of the 
5-aminopentyl phosphonate than the pentyl phosphonate in inhibiting hista- 
mine release is, however, unlike the reaction of these compounds with chymo- 
trypsin (4).  Nevertheless, the likenesses are sufficient to suggest that chymo- 
trypsin and the homocytotropic antibody-activated esterase of rat peritoneal 
mast cells are parazymes; i.e., enzymes which have a similar although not iden- 
tical specificity (cf. reference 4). How valid this suggestion is, and what if any 
relation the antigen-antibody-activated esterase bears to the already activated 
chymotrypsinlike enzyme known to be present in rat peritoneal mast cells (23) 
must be left for future work to decide (cf. reference 20). 
Comparison of the Activity of Phosphonate Esters in the ttomocytotropic Anti- 
body-Mediated Reactions of the Rat Mast Cell and Guinea Pig Lung Slice.--The 
arithmetic dose response curve (Fig. 3, A  and B) found for the action of the 
phosphonates on  the  antigen-induced histamine release  from rat  peritoneal ELMER  L.  BECKER  AND  K.  FRANK  AUSTEN  391 
mast cells is in distinct contrast to the logarithmic relationship found when these 
same phosphonates inhibited the sensitized guinea pig lung system (4). The two 
different kinds of dose response curves imply a difference in the detailed mode 
of histamine release from the mast cells  of the guinea pig lung  and the rat 
peritoneum. In view of the striking variations in their  reactivity to chemical 
histamine release (1, 24) and the morphologic differences demonstrated for the 
mast cells of the two species (25, 26) this is not unexpected. Alternatively, the 
form of the dose response curve given by the phosphonates acting on the guinea 
pig lung reaction might have been determined by possible difficulties of access 
of the phosphonates or the antigen to the target cell imbedded in the lung tis- 
sue. Finally, it should be recalled that even the mediating homocytotropic an- 
tibodies in the two species are somewhat different; i.e., the guinea pig antibody 
is present in antisera in high concentration, is sulfhydryl resistant, and heat 
stable (27, 28), whereas, the rat antibody is present in trace amounts, is sulfhy- 
dryl sensitive, and heat labile (8, 9, 29). 
Structural variations of the phosphonates had different effects on their ability 
to suppress the reaction in the two species.  In the guinea pig lung system, the 
phenylalkyl phosphonates exhibited a sharp peak of activity with benzyl phos- 
phonate; with the rat peritoneal mast cells the inhibitory activity increased 
progressively with increasing chain length, so that peak activity was observed 
with the phenylpropyl phosphonate (Fig. 4, A). The 5-aminopentyl phospho- 
nate was less inhibitory than the pentyl phosphonate in the sensitized guinea 
pig lung system, but more inhibitory in the rat mast cell reaction. On the other 
hand, there is a  relatively small difference in the pattern of response of the 
chloroalkyl phosphonates in the two systems (reference 4 and Fig. 4, B).  8 
These differences in the inhibitory pattern of the phosphonates found in the 
guinea pig and rat systems are much greater than what has been observed in 
regard to the action of these same compounds on guinea pig and rat Cqa from 
different species.  This is evident in Fig. 1 where the similarity of action of the 
phosphonates on C'la from guinea pig, and rat is seen,  and also in reference 
30, Fig. 2, showing the inhibition of rabbit Cqa. The same sort of species simi- 
larity was present when the action of the phosphonates was tested on acetyl- 
choline esterase from rabbit, guinea pig, and human erythrocytes (35). 
The enzymatic breakdown of the phosphonates by the guinea pig lung slices 
(4) or by the rat peritoneal mast cells is negligible so that the variability of the 
two species in this regard can be discounted. Thus, the differences in the re- 
sponse of the guinea pig lung slices and rat peritoneal mast cells to inhibition by 
8  In the work on the sensitized guinea pig lung system, described in reference 4, an error 
in the calculation  of the concentration  of the 5-chloropentyl  phosphonate led to a PI~o which 
was less than the true pI~o. When this error was corrected, the pI~o, 3.41, is essentially  the 
same as the pI~o for the 4-chlorobutyl  phosphonate, 3.3~ determined  at the same time in the 
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the phosphonates imply that two different antigen-antibody-activated  esterases 
are involved in the homocytotropic antibody-mediated histamine release from 
the two systems. 
Comparison of the Esterase Involved in Homocytotropic Antibody-Mediated Re- 
lease of ttistamine from Rat Mast Cells with Rat C'la.--The phosphonates give 
a decidedly different pattern of inhibition when acting on the homocytotropic 
antibody-mediated release of histamine from rat peritoneal mast cells than 
when reacting with C'la of rat or guinea pig complement (Figs. 1 and 4). Among 
the phenylalkyl phosphonates,  the phenyl phosphonate was the most active in- 
hibitor of rat C'la and the phenylethyl phosphonate was the least (Fig. 1). In 
the rat mast cell reaction the inhibitory potency increased  regularly with in- 
creasing distance of the phenyl ring from the phosphorus  atom,  the phenyl- 
prowl phosphonate being the most effective (Fig. 4, A). The inhibitory pat- 
terns of the chloroalkyl series in the two reactions were also quite different. The 
inhibition of C'la was maximum with the 4-chlorobutyl phosphonate and de- 
creased with the 5-chloropentyl  phosphonate. In contrast, the 5-chloropentyl 
phosphonate was more active in the rat mast cell reaction than the 4-chlorobutyl 
phosphonate. 
As already pointed out, the hydrolysis of the phosphonates by the sensitized 
or unsensitized mast cell or erythrocyte is negligible. The differences in inhibi- 
tory activity of the phosphonates therefore,  can not be attributable to differ- 
ences in the ability of these cells to break down the phosphonates.  The present 
studies also eliminate the possibility that unequal access of the phosphonates to 
the target cell might account for the differences found, since the effect of the 
phosphonates was compared on two kinds of cell suspension, the mast cell and 
the red cell. Thus, the results with the rat peritoneal mast cells lead to the same 
conclusion as the previous work with guinea pig lung slices; i.e., the antigen- 
antibody-activated  esterase involved in the homocytotropic  antibody-mediated 
release of histamine is not part of the complement system. 
SUMMARY 
The ability of a number of p-nitrophenylethyl,  alkyl phenylalkyl,  chloroalkyl, 
and aminoalkyl phosphonates to inhibit the homocytotropic antibody-medi- 
ated release of histamine from rat peritoneal mast cells has been tested. The 
effectiveness of these same phosphonates against the activated first component 
of rat complement (C'la) has also been investigated. 
The rat mast cell esterase activated by the reaction of antigen and homocyto- 
tropic antibody resembles chymotrypsin in its reactivity with the phenylalkyl 
and chloroalkyl phosphonate, but is unlike this protease in its greater respon- 
siveness to the 5-aminopentyl phosphonate relative to the pentyl phosphonate. 
The antigen-homocytotropic  antibody-activated mast cell esterase and chymo- 
trypsin, thus, appear to be similar,  but different enzymes;  i.e., they are para- 
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There are distinct differences in the pattern of inhibition given by the phenyl- 
alkyl  and  aminoalkyl  and  alkyl  phosphonates  of  the  homocytotropic anti- 
body-medlated histamine release from rat peritoneal mast cells and from guinea 
pig lung slices. On the basis of these differences it is concluded that the esterases 
activated by the combination of antigen and homocytotropic antibody on the 
mast cells of the two species are not the same. 
The arithmetic dose response curve found for the action of the phosphonates 
on the antigen-induced histamine release from rat peritoneal mast cells con- 
trasted sharply with the logarithmic relationship found when these same in- 
hibitors acted on the guinea pig lung system. This suggests that in addition to 
the  antigen-antibody-activated esterases being unlike,  the detailed mode of 
histamine release from the mast cells of the guinea pig lung differs from that of 
the mast cells of the rat peritoneum. 
Distinct and large differences were found in the pattern of inhibition of his- 
tamine  release from rat  peritoneal mast  cells and  of rat  C'la  given by the 
phenylalkyl, and chloroalkyl and alkyl phosphonates implying that esterase ac- 
tivated by the combination of antigen with the sensitized rat peritoneal mast 
cells is not C'la. Thus, the results with the peritoneal mast cells lead to the same 
conclusion as the previous work with guinea pig lung slices; i.e., the antigen- 
antibody-activated esterase involved in  the homocytotropic antibody-medi- 
ated release of histamine is not part of the complement system. 
We acknowledge  with gratitude the expert assistance given by Miss Cynthia Laitman and 
Mrs. Marjorie McCormick, and the gift of certain of the phosphonates by Mr. Louis Hafner. 
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